Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Shares Issued (2017 - 2025)

INVO Fertility (IVF) has disclosed Shares Issued for 12 consecutive years, with -$7.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to -$7.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a 8507.48% increase, with the full-year FY2024 number at $900611.0, up 3807.04% from a year prior.
  • Shares Issued was -$7.7 million for Q3 2025 at INVO Fertility, down from $8.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $8.7 million in Q1 2025 to a low of -$7.7 million in Q3 2025.
  • A 5-year average of $185524.7 and a median of $69281.0 in 2021 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 22808.83% in 2023; the steepest drop was 56001.46% in 2023.
  • INVO Fertility's Shares Issued stood at $123562.0 in 2021, then crashed by 91.75% to $10200.0 in 2022, then crashed by 56001.46% to -$5.7 million in 2023, then skyrocketed by 112.9% to $735480.0 in 2024, then plummeted by 1147.44% to -$7.7 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Shares Issued are -$7.7 million (Q3 2025), $8.7 million (Q1 2025), and $735480.0 (Q4 2024).